**Comparing Knee Ligament Laxity and Torn Ligaments: Orthobiologic Interventions vs. Surgical Options – Insights from Regenexx** Knee ligament injuries are...

**Comparing Knee Ligament Laxity and Torn Ligaments: Orthobiologic Interventions Versus Surgical Options – A Regenexx Perspective** Knee ligament injuries are...

**Comparing Treatment Options for Knee Ligament Laxity and Torn Ligaments: Interventional Orthobiologics Versus Surgical Approaches – A Regenexx Perspective** Knee...

# Comparing Knee Ligament Laxity and Torn Ligaments: Orthobiologic Interventions vs. Surgical Treatment – Regenexx Knee injuries are among the...

# Comparing Knee Ligament Laxity and Torn Ligaments: Orthobiologic Interventions vs. Surgical Options – Regenexx Knee injuries are among the...

**Comparing Knee Ligament Laxity and Torn Ligaments: Orthobiologic Interventions vs. Surgical Treatments – Insights from Regenexx** Knee injuries are a...

# Comparing Knee Ligament Laxity and Torn Ligaments: Orthobiologic Interventions vs. Surgical Treatment – Insights from Regenexx Knee injuries are...

**Comparing Treatment Approaches for Knee Ligament Laxity and Torn Ligaments: Interventional Orthobiologics Versus Surgical Options – A Regenexx Perspective** Knee...

**Understanding Golfer’s Knee: Causes, Symptoms, and Treatment Options** Golf is a sport that combines precision, skill, and physical endurance. While...

# Effective Treatment of Thrombotic Microangiopathy in Pediatric Patients Post-Allogeneic Hematopoietic Stem Cell Transplantation Using Defibrotide: A Single-Center Study from...

**Rational Design of a Mouse Cell Fate Controller: A Study Published in Nature Communications** In the ever-evolving field of biotechnology,...

**Designing a Mouse Cell Fate Controller Through Rational Engineering** In recent years, the field of synthetic biology has made significant...

**Effective Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy in Pediatric Patients Using Defibrotide: A Report from a Chinese...

**Rational Design of Mouse Cell Fate Controller: A Study Published in Nature Communications** In a groundbreaking study published in *Nature...

**Rational Design of Mouse Cell Fate Controller Published in Nature Communications** In a groundbreaking study published in *Nature Communications*, researchers...

**Gene Therapy Trial Evaluates Efficacy of Cancer-Targeting Virus in Treating Brain Tumors** In the ever-evolving landscape of cancer treatment, gene...

### 2024 PRP Randomized Controlled Trial Infographic 2.0 by Regenexx: A Comprehensive Overview In the ever-evolving field of regenerative medicine,...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: Histological and Biochemical...

**Comparative Analysis of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and Biochemical Study –...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and...

**Jonathan Thomas Appointed as New President and CEO of CIRM** In a significant development for the field of regenerative medicine,...

# $53 Million Allocated for Clinical and Translational Research Funding: A Leap Forward in Medical Innovation In a significant move...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Implications for Cell Death and Disease** The human...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Insights from Cell Death & Disease** Human epidermal...

**Correction Notice: Influence of Thyroid Hormone Receptor β on Cancer Stem Cell Activity – Oncogene** In the ever-evolving field of...

**Nevada Approves Controversial Unproven Therapies, Joining Other States in Challenging FDA Regulations on Biologics** In a move that has sparked...

**QC Kinetix Shifts Focus from Upselling to Cost Reduction – Regenexx Reports** In the ever-evolving landscape of regenerative medicine, QC...

# Effective Approaches for Modeling Aging and Age-Related Diseases Aging is an inevitable biological process that affects all living organisms....

**Infographic on the 2024 PRP Randomized Controlled Trial by Regenexx: A Comprehensive Overview** In the ever-evolving field of regenerative medicine,...

# Semaphorin 3C (Sema3C) Modulates Stromal Microenvironment to Facilitate Hepatocellular Carcinoma Advancement – Insights from Signal Transduction and Targeted Therapy...

How to Produce Standardized hPSC-Derived Cardiomyocyte Aggregates in Stirred Spinner Flasks: A Guide from Nature Protocols

Producing standardized human pluripotent stem cell (hPSC)-derived cardiomyocyte aggregates in stirred spinner flasks is a crucial step in the field of regenerative medicine and drug discovery. These aggregates, also known as cardiac spheroids, mimic the three-dimensional structure and function of the heart, making them an invaluable tool for studying cardiac development, disease modeling, and drug screening. In a recent article published in Nature Protocols, researchers have outlined a detailed protocol for generating high-quality hPSC-derived cardiomyocyte aggregates in stirred spinner flasks. Here, we will provide an overview of the key steps involved in this protocol.

First and foremost, it is essential to start with high-quality hPSCs that have been properly maintained and characterized. These cells should be cultured in a pluripotent state using appropriate culture media and conditions. Once the hPSCs are ready, they can be differentiated into cardiomyocytes using a well-established cardiac differentiation protocol. This typically involves the sequential addition of growth factors and small molecules that mimic the signaling pathways involved in cardiac development.

After the cardiomyocytes have been generated, they can be seeded into stirred spinner flasks for aggregate formation. The use of stirred spinner flasks allows for efficient mixing and oxygenation of the cells, which is crucial for promoting uniform aggregate formation. The researchers recommend using a specific type of spinner flask with a magnetic stir bar for optimal results.

To promote aggregation, the cardiomyocytes are typically cultured in a suspension culture medium that contains essential nutrients and growth factors. The researchers suggest using a defined medium that supports cardiomyocyte survival and maturation. It is also important to monitor the pH and oxygen levels in the culture medium to ensure optimal conditions for aggregate formation.

During the culture period, the researchers recommend gently shaking the spinner flasks at a low speed to promote aggregate formation without disrupting the cells. It is also important to regularly check the size and morphology of the aggregates under a microscope to ensure uniformity and quality. The researchers provide guidelines for determining the optimal seeding density and culture duration to achieve standardized cardiomyocyte aggregates.

In conclusion, producing standardized hPSC-derived cardiomyocyte aggregates in stirred spinner flasks is a complex process that requires careful attention to detail and adherence to specific protocols. By following the guidelines outlined in the Nature Protocols article, researchers can generate high-quality cardiac spheroids that can be used for a wide range of applications in cardiovascular research. This protocol represents a significant advancement in the field of stem cell biology and holds great promise for advancing our understanding of cardiac development and disease.